1. Home
  2. RLMD vs EVF Comparison

RLMD vs EVF Comparison

Compare RLMD & EVF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLMD
  • EVF
  • Stock Information
  • Founded
  • RLMD 2004
  • EVF 1998
  • Country
  • RLMD United States
  • EVF United States
  • Employees
  • RLMD N/A
  • EVF N/A
  • Industry
  • RLMD Biotechnology: Pharmaceutical Preparations
  • EVF Investment Managers
  • Sector
  • RLMD Health Care
  • EVF Finance
  • Exchange
  • RLMD Nasdaq
  • EVF Nasdaq
  • Market Cap
  • RLMD 110.6M
  • EVF 112.0M
  • IPO Year
  • RLMD N/A
  • EVF N/A
  • Fundamental
  • Price
  • RLMD $3.16
  • EVF $6.23
  • Analyst Decision
  • RLMD Hold
  • EVF
  • Analyst Count
  • RLMD 2
  • EVF 0
  • Target Price
  • RLMD $7.50
  • EVF N/A
  • AVG Volume (30 Days)
  • RLMD 110.4K
  • EVF 93.3K
  • Earning Date
  • RLMD 11-07-2024
  • EVF 01-01-0001
  • Dividend Yield
  • RLMD N/A
  • EVF 10.68%
  • EPS Growth
  • RLMD N/A
  • EVF N/A
  • EPS
  • RLMD N/A
  • EVF 0.94
  • Revenue
  • RLMD N/A
  • EVF N/A
  • Revenue This Year
  • RLMD N/A
  • EVF N/A
  • Revenue Next Year
  • RLMD N/A
  • EVF N/A
  • P/E Ratio
  • RLMD N/A
  • EVF $6.74
  • Revenue Growth
  • RLMD N/A
  • EVF N/A
  • 52 Week Low
  • RLMD $1.88
  • EVF $5.20
  • 52 Week High
  • RLMD $7.22
  • EVF $6.84
  • Technical
  • Relative Strength Index (RSI)
  • RLMD 39.24
  • EVF 50.20
  • Support Level
  • RLMD $3.06
  • EVF $6.23
  • Resistance Level
  • RLMD $3.43
  • EVF $6.30
  • Average True Range (ATR)
  • RLMD 0.20
  • EVF 0.04
  • MACD
  • RLMD -0.04
  • EVF 0.00
  • Stochastic Oscillator
  • RLMD 16.30
  • EVF 38.20

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

About EVF Eaton Vance Senior Income Trust

Eaton Vance Senior Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to provide a high level of current income consistent with the preservation of capital, by investing in senior, secured floating-rate loans. The trust invests in below-investment-grade floating-rate loans, which are considered speculative because of the credit risk of their issuers. Its portfolio of investment consists of aerospace and defense, automotive, beverage, building and development, business equipment and services, cable and satellite television, and other areas.

Share on Social Networks: